The transcriptional regulation of normal and malignant blood cell development. (2022)
Attributed to:
Finding therapeutic targets in FLT3-ITD AML using a systems biology approach
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/febs.15735
PubMed Identifier: 33511785
Publication URI: http://europepmc.org/abstract/MED/33511785
Type: Journal Article/Review
Volume: 289
Parent Publication: The FEBS journal
Issue: 5
ISSN: 1742-464X